MML Investors Services’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,644
Closed -$399K 2489
2023
Q4
$399K Buy
3,644
+435
+14% +$45K ﹤0.01% 1883
2023
Q3
$324K Sell
3,209
-373
-10% -$42.9K ﹤0.01% 1875
2023
Q2
$487K Buy
3,582
+825
+30% +$101K ﹤0.01% 1647
2023
Q1
$286K Sell
2,757
-678
-20% -$65.6K ﹤0.01% 1698
2022
Q4
$304K Sell
3,435
-236
-6% -$19.6K ﹤0.01% 1764
2022
Q3
$294K Buy
3,671
+351
+11% +$33.1K ﹤0.01% 1682
2022
Q2
$318K Buy
3,320
+138
+4% +$16.6K ﹤0.01% 1640
2022
Q1
$473K Buy
3,182
+74
+2% +$10.3K ﹤0.01% 1480
2021
Q4
$441K Buy
3,108
+157
+5% +$22.2K ﹤0.01% 1487
2021
Q3
$386K Buy
2,951
+457
+18% +$59.8K ﹤0.01% 1501
2021
Q2
$343K Buy
2,494
+366
+17% +$50.1K ﹤0.01% 1532
2021
Q1
$278K Sell
2,128
-210
-9% -$25.3K ﹤0.01% 1550
2020
Q4
$262K Buy
+2,338
New +$221K ﹤0.01% 1457

Other funds holding CNMD

MML Investors Services's CNMD Position: Q1 2024 in Review

MML Investors Services sold out of CONMED (CNMD) in Q1 2024, closing a stake of 3,644 shares — an estimated $399K sold.

MML Investors Services first reported a position in CNMD in Q4 2020 and held it in 13 quarters. The position peaked at $487K in Q2 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • MML Investors Services reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • MML Investors Services sold 3,644 CONMED shares in Q1 2024, an estimated $399K.
  • MML Investors Services first reported a position in CONMED in Q4 2020 and held it in 13 quarters.
  • MML Investors Services's CONMED position peaked at $487K in Q2 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on MML Investors Services's 13F filing for Q1 2024, filed 14 May 2024.